Mylan Pharmaceuticals has introduced Alfuzosin Hydrochloride Extended-release Tablets, 10mg.Mylan’s Alfuzosin Hydrochloride Extended-release Tablets, 10mg are generic equivalent to Uroxatral, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Uroxatral belongs to a group of drugs called alpha-adrenergic blockers.Uroxatral relaxes the muscles in the prostate and bladder neck, making it easier to urinate.
Related stories
Your Laboratory Freezer Just Alarmed: A Lab Manager’s Response Plan to Protect Irreplaceable Samples
Regulatory Strategy for Early-Stage Biotech and Medtech Companies
BioNTech and Gilead Partner for Pumitamig Clinical Trial
Never miss a pharmaceutical headline
The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.
- The top pharma and life sciences stories, straight to your inbox
- The biggest news, features, interviews, and analysis
- Dedicated coverage of the key developments driving the global pharmaceutical sector
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Latest stories
Related stories
Your Laboratory Freezer Just Alarmed: A Lab Manager’s Response Plan to Protect Irreplaceable Samples
Regulatory Strategy for Early-Stage Biotech and Medtech Companies
BioNTech and Gilead Partner for Pumitamig Clinical Trial
Cencora to Acquire American Oncology Network in $2.4 Billion Deal
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access theMedia Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back

















